Xril AM Syrup
Images are for reference. Actual packaging may vary.
Ambroxol (30mg/5ml) + Guaifenesin (100mg/5ml) + Menthol (5mg/5ml) + Terbutaline (1.25mg/5ml)
Bottle of 100 ml • Syrup
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+3 more active ingredients
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Terbutaline stimulates beta-2 adrenergic receptors, causing relaxation of bronchial smooth muscle and dilation of airways.
Guaifenesin reduces mucus viscosity by increasing the hydration of secretions in the respiratory tract, facilitating easier expectoration.
Medical applications
Xril AM Syrup is a multi-ingredient expectorant and bronchodilator formulation designed to alleviate symptoms associated with respiratory tract disorders characterized by excessive mucus production and bronchospasm. Each 5 ml of syrup contains Ambroxol 30 mg, Guaifenesin 100 mg, Menthol 5 mg, and Terbutaline 1.25 mg. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus, thereby improving airway patency.
Guaifenesin serves as an expectorant, promoting the expulsion of mucus from the respiratory tract. Menthol provides a soothing effect on the mucous membranes and imparts a cooling sensation that may help relieve throat irritation and cough reflex sensitivity. Terbutaline, a selective β2-adrenergic receptor agonist, exerts bronchodilatory effects by relaxing bronchial smooth muscles, thus improving airflow and reducing bronchospasm.
Xril AM Syrup is indicated for the symptomatic management of productive cough associated with bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions involving mucus hypersecretion and airway constriction. It should be used under medical supervision, with caution advised in patients with cardiovascular disorders, hyperthyroidism, or hypersensitivity to any component.
The syrup is intended for oral administration, with dosage and duration tailored according to clinical response and physician guidance.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Xril AM Syrup







